Impaired portal circulation resulting from L-arginine deficiency in patients with lysinuric protein intolerance
- PMID: 16966712
- PMCID: PMC1856429
- DOI: 10.1136/gut.2005.086603
Impaired portal circulation resulting from L-arginine deficiency in patients with lysinuric protein intolerance
Conflict of interest statement
Conflict of interest: None declared.
Similar articles
-
Renal handling of diamino acids in lysinuric protein intolerance.J Clin Invest. 1974 Jul;54(1):9-17. doi: 10.1172/JCI107753. J Clin Invest. 1974. PMID: 4600043 Free PMC article. Clinical Trial.
-
[Lysinuric protein intolerance: a severe hyperammonemia secondary to l-arginine deficiency (author's transl)]].Arch Fr Pediatr. 1981 Dec;38 Suppl 1:829-35. Arch Fr Pediatr. 1981. PMID: 6800334 French.
-
The genetics of heteromeric amino acid transporters.Physiology (Bethesda). 2005 Apr;20:112-24. doi: 10.1152/physiol.00051.2004. Physiology (Bethesda). 2005. PMID: 15772300 Review.
-
[Physiological and pathological aminoacidurias].Monatsschr Kinderheilkd (1902). 1973 May;121(5):190-200. Monatsschr Kinderheilkd (1902). 1973. PMID: 4713389 German. No abstract available.
-
[Lysinuric protein intolerance and other cationic aminoacidurias].Ryoikibetsu Shokogun Shirizu. 1998;(19 Pt 2):562-4. Ryoikibetsu Shokogun Shirizu. 1998. PMID: 9645134 Review. Japanese. No abstract available.
Cited by
-
Overview of symptoms and treatment for lysinuric protein intolerance.J Hum Genet. 2019 Sep;64(9):849-858. doi: 10.1038/s10038-019-0620-6. Epub 2019 Jun 18. J Hum Genet. 2019. PMID: 31213652 Review.
-
Lysinuric protein intolerance in a family of Mexican ancestry with a novel SLC7A7 gene deletion. Case report and review of the literature.Mol Genet Metab Rep. 2015 Jan 10;2:47-50. doi: 10.1016/j.ymgmr.2014.12.005. eCollection 2015 Mar. Mol Genet Metab Rep. 2015. PMID: 28649527 Free PMC article.
References
-
- Simell O. Lysinuric protein intolerance and other aminocidurias. In: Scriver CR, Beaudet AL, Sly WS, et al eds. The metabolic and molecular bases of inherited disease, vol 3, 7th edn. New York: McGraw‐Hill, 19953603–3627.
-
- Kilbourn R G, Belloni P. Endothelial cell production of nitrogen oxides in response to interferon γ in combination with tumor necrosis factor, inteleukin‐1, and endotoxin. J Natl Cancer Inst 199082772–776. - PubMed
-
- Palmer R M J, Ferrige A G, Moncada S. Nitric oxide release accounts for the biological activity of endothelium‐derived relaxing factor. Nature 1987327524–526. - PubMed
-
- Rubanyi G M, Romero J C, Vanhoutte P M. Flow‐induced release of endothelium‐derived relaxing factor. Am J Physiol 1986250H1145–H1149. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources